HIGHER PREDICTIVE POWER OF EPIGENETIC SIGNATURES FOR RESPONSE TO VEDOLIZUMAB AND USTEKINUMAB IN ANTI-TNF NAIVE PATIENTS WITH ACTIVE CROHN'
van Zon S., Joustra V., Yim AYL., Henneman P., Hageman I., de Waard T., Levin E., Noble A., Chapman T., McGregor C., Adams A., Satsangi JJ., De Jonge WJ., D'Haens G.